Metabolic-Fit / 100
Metaboost Rx review
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
Metaboost publishes two clean per-drug prices — semaglutide from $149 a month, tirzepatide from $199 against a struck-through $299 — which is more than several of its siblings manage. Then you reach the legal pages, where the company address is given three times as "123 Example Street, Suite 100, Your City, WI, 92308". That is an unfilled template placeholder, live, on a site selling prescription medication. The ZIP belongs to California and the state abbreviation to Wisconsin.
- Confirm HSA / FSA coverage
- Public information reviewed
- Confirm your total cost
Metaboost Rx at a glance
- Semaglutide
- From $149/mo
- Tirzepatide
- From $199/mo
- Coverage
- Not published; described only as "nationwide"
- Brand-name
- Compounded only
How we scored Metaboost Rx
Every factor comes from Metaboost Rx's own published pricing, disclosures and oversight, and the six combine into the 27/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.
Cost is unpredictable or sits at the premium end.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Support is thin once the prescription ships.
Oversight and lab support fall short of the best on our list — the review below says exactly where.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we checked this review
Compounded semaglutide is listed from $149 a month and tirzepatide from $199 against a struck-through $299, each including the provider visit, prescription, delivery and check-ins. The company address in its own policies is an unfilled template placeholder — "123 Example Street, Suite 100, Your City, WI, 92308", printed three times, pairing a Wisconsin state code with a California ZIP. Coverage is described only as nationwide with no state list, and four stat counters render as zeros, including "0 + Patients supported" and "0.0 /5 Average care rating".
Before you sign up
What Metaboost Rx's public site and signup page show before you hand over any details.
Worth knowing
- No monthly price is visible on the public homepage; the number appears only after you begin the intake
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $149 | Flat monthly"GLP-1 Semaglutide Injection from $149/mo", listed as including the online provider visit, prescription, delivery and ongoing check-ins. |
| Compounded tirzepatide | $199 | Flat monthly"GLP-1 Tirzepatide Injection from $199/mo" against a struck-through $299, same inclusions. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Metaboost Rx's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Publishes a real price for each drug rather than a single undifferentiated figure
- "Flat-rate pricing. One clear price. No insurance games", with the visit, prescription, delivery and check-ins itemized as included
- "$0 if not approved" is stated plainly
- Carries the disclosure that compounded medications are not FDA-approved and are not the same as the branded ones
The caveats
- The company address is a template placeholder — "123 Example Street, Suite 100, Your City, WI, 92308" — printed three times in its own policies
- That placeholder pairs a Wisconsin state code with a California ZIP, so it is not even internally plausible
- Coverage is described only as "nationwide" with no state list, while the site simultaneously says "Oklahoma City & nationwide"
- Four stat counters render as zeros: "0 + Patients supported", "0.0 /5 Average care rating", "0 Provider-supervised treatments", "0 % Plans provider-reviewed"
- "Avg. trajectory wk 24 −18 lbs" is presented as a result with no source
- Both prices are "from", so dose may move them
An inexpensive offer with missing business details
MetaBoost RX advertises compounded semaglutide from $149 per month and compounded tirzepatide from $199 per month. The tirzepatide page also displays a $299 reference figure. A crossed-out or reference price is not the amount to budget when the service is offering another charge. At the same time, the word “from” means the lower figure needs confirmation for your prescribed dose, supply, and renewal before it becomes a reliable ongoing estimate.
The advertised package includes the visit, prescription, delivery, and check-ins, and the service says nothing is charged if an applicant is not approved. That gives a useful outline of the offer. Ask when approval triggers payment and whether the same total applies after a dose change. Although the company uses flat-rate language, that broad claim sits alongside starting-price qualifiers. A written prescription-specific total would settle that tension more clearly than choosing whichever phrase sounds most favorable.
A placeholder address is a reason to ask
The public site prints “123 Example Street, Suite 100, Your City, WI, 92308” as its address. That is placeholder text, not a usable location for identifying the practice. It should not be treated as proof of a Wisconsin clinic or a California operation based on the ZIP code. Before sharing sensitive information or paying, ask for the operating entity's legal name, a functioning business address, and the identity of the medical group providing care.
MetaBoost RX also uses nationwide language and marketing connected with Oklahoma City, without publishing a state-by-state availability list. Those statements do not establish that a clinician is licensed where you live. Confirm eligibility directly using your residence. This is a basic identification question rather than a judgment about any individual's medical competence. A company that can clearly name its medical group, clinician, and dispensing pharmacy is easier to evaluate than one relying on broad geographic claims.
Treat the figures as claims, not outcomes
The site includes a week-by-week weight trajectory that reaches an 18-pound reduction at week 24, without an identified source supporting that particular presentation. It should not be read as a forecast for your treatment. Several counters also display zeroes. Those broken or incomplete statistics do not establish that the business has served no patients, just as an attractive graph does not establish a measured result for its compounded prescriptions.
The company acknowledges that compounded medications are not FDA approved and are not the branded medicines. Keep that distinction when discussing options with a clinician. The decision should include why a particular formulation is being proposed, the pharmacy filling it, and the instructions that accompany the product. Neither a low price nor a smooth delivery promise substitutes for those details. Ask how to obtain clinical advice if the medication is delayed, the instructions are unclear, or treatment needs to change.
Decide whether the answers close the gaps
The promise of check-ins is helpful only if you know what they involve. Ask whether they are scheduled clinical appointments, messaging, or another form of contact, and how urgent concerns are handled. No specific maternal-health expertise is established by the general weight-loss marketing. If pregnancy planning, breastfeeding, or postpartum circumstances are relevant, the service needs to address them individually instead of relying on a generic personalized-care statement.
MetaBoost RX's low starting prices could justify an information request, but the placeholder address leaves an important question unresolved. Obtain the business identity, state eligibility, pharmacy name, recurring total, and cancellation terms before deciding to join. The $0-if-not-approved claim should also be separated from refunds after medication is prepared. When these details are clear, you can compare the service's actual offer; until then, the advertised monthly figure is only part of the information needed.
The bottom line for mothers
Best for: Hard to recommend while the site cannot say where the company is.
Alternatives to Metaboost Rx
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge Rx86
Metabolic-Fit / 100
CoreAge RxFeatured partnerCoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
- Visit Lttl56
Metabolic-Fit / 100
Compounded semaglutide at $99 a month and tirzepatide at $149, month to month and the same price at every dose, plus a separate microdose line for anyone who wants a gentler metabolic effect rather than maximum weight loss. Lttl covers all 50 states and Washington D.C., says it prescribes and ships within 48 hours, and attributes compounding to U.S.A.-licensed pharmacies it does not name. The catalog runs well past weight loss into NAD+, sermorelin, glutathione and B12 from $79, so read the longevity menu as a separate business from the GLP-1 you came for. Prepaying for a year brings it to $89 and $139 a month, and the first-order discount of up to $140 is promotional.
- Visit Peter MD36
Metabolic-Fit / 100
Real pre-intake pricing on its GLP-1 pages ($149/mo semaglutide-class B12 combo, $249/mo tirzepatide billed quarterly) inside a much broader TRT-and-men's-health platform — with a strict cancellation policy that refuses cancellations inside 48 hours of a renewal.
Providers like Metaboost Rx
Keep comparing Metaboost Rx
Head-to-head & alternatives
Ranked boards
- Best GLP-1 for women
- Best GLP-1 for PCOS & insulin resistance
- Best GLP-1 for perimenopause
- Best GLP-1 while breastfeeding (safety-first)
- Cheapest GLP-1 programs
- Compounded tirzepatide providers
- Cheapest tirzepatide online
- Cheapest semaglutide online
- Where to get Zepbound online
- Semaglutide vs tirzepatide: which is right for you
Metaboost Rx, answered
- How much does Metaboost Rx cost?
- At last review, Metaboost Rx's lowest ongoing compounded rate was about $149/mo — From $149/mo for semaglutide, From $199/mo for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is Metaboost Rx safe to use while breastfeeding?
- None of these drugs is established as safe in pregnancy, so stopping before you try to conceive is the usual plan. If you are nursing, the Wegovy injection, Ozempic, Zepbound and Mounjaro labels say there is little or no data on the drug in breast milk, and they leave it to you and your clinician to weigh the benefits of breastfeeding against your need for treatment. Compounded versions carry no label of their own; ask the prescriber directly how they handle nursing patients. Metaboost Rx is not an exception to any of that — settle the timing with your own clinician.
- Does Metaboost Rx offer both semaglutide and tirzepatide?
- Yes — Metaboost Rx offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- How does Metaboost Rx score for mothers?
- Metaboost Rx scores 27/100 on our Metabolic-Fit Score, a weighted read of six things mothers actually have to care about. CoreAge Rx, a featured partner, is worth a side-by-side look.
Pricing, states and verification reflect Metaboost Rx's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.